Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» OTL-201
OTL-201
ASH 2022 – Orchard gets a Sanfilippo boost
EP Vantage
Tue, 12/13/22 - 10:24 am
ASH 2022
Orchard Therapeutics
Sanfillipo Syndrome
gene therapies
OTL-201